Mellinghoff IK - Search Results

1

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.

Mellinghoff IK, Lu M, Wen PY, Taylor JW, Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum MK, Chun S, Le K, Tassinari A, Choe S, Toubouti Y, Schoenfeld S, Pandya SS, Hassan I, Steelman L, Clarke JL, Cloughesy TF. Mellinghoff IK, et al. Nat Med. 2023 Mar;29(3):615-622. doi: 10.1038/s41591-022-02141-2. Epub 2023 Feb 23. Nat Med. 2023. PMID: 36823302 Free PMC article. Clinical Trial.

2

Virchow 2011 or how to ID(H) human glioblastoma.

DeAngelis LM, Mellinghoff IK. DeAngelis LM, et al. Among authors: mellinghoff ik. J Clin Oncol. 2011 Dec 1;29(34):4473-4. doi: 10.1200/JCO.2011.37.5873. Epub 2011 Oct 24. J Clin Oncol. 2011. PMID: 22025161 No abstract available.

3

PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors.

Mellinghoff IK, Cloughesy TF, Mischel PS. Mellinghoff IK, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):378-81. doi: 10.1158/1078-0432.CCR-06-1992. Clin Cancer Res. 2007. PMID: 17255257 Review.

4

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability.

Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL. Mellinghoff IK, et al. Cancer Cell. 2004 Nov;6(5):517-27. doi: 10.1016/j.ccr.2004.09.031. Cancer Cell. 2004. PMID: 15542435 Free article.

5

Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.

Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J, Phelps ME, Silverman DH, Sawyers CL, Czernin J. Waldherr C, et al. Among authors: mellinghoff ik. J Nucl Med. 2005 Jan;46(1):114-20. J Nucl Med. 2005. PMID: 15632041 Free article.

6

IQGAP1 controls tight junction formation through differential regulation of claudin recruitment.

Tanos BE, Perez Bay AE, Salvarezza S, Vivanco I, Mellinghoff I, Osman M, Sacks DB, Rodriguez-Boulan E. Tanos BE, et al. J Cell Sci. 2015 Mar 1;128(5):853-62. doi: 10.1242/jcs.118703. Epub 2015 Jan 14. J Cell Sci. 2015. PMID: 25588839 Free PMC article.

7

Epidermal growth factor receptor inhibitors in oncology.

Vivanco I, Mellinghoff IK. Vivanco I, et al. Among authors: mellinghoff ik. Curr Opin Oncol. 2010 Nov;22(6):573-8. doi: 10.1097/CCO.0b013e32833edbdf. Curr Opin Oncol. 2010. PMID: 20739887 Review.

8

Cocaine and Buerger disease: is there a pathogenetic association?

Marder VJ, Mellinghoff IK. Marder VJ, et al. Among authors: mellinghoff ik. Arch Intern Med. 2000 Jul 10;160(13):2057-60. doi: 10.1001/archinte.160.13.2057. Arch Intern Med. 2000. PMID: 10888980

9

Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation.

Mellinghoff I, Daibata M, Humphreys RE, Mulder C, Takada K, Sairenji T. Mellinghoff I, et al. Virology. 1991 Dec;185(2):922-8. doi: 10.1016/0042-6822(91)90574-u. Virology. 1991. PMID: 1660209

10

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.

Gera JF, Mellinghoff IK, Shi Y, Rettig MB, Tran C, Hsu JH, Sawyers CL, Lichtenstein AK. Gera JF, et al. Among authors: mellinghoff ik. J Biol Chem. 2004 Jan 23;279(4):2737-46. doi: 10.1074/jbc.M309999200. Epub 2003 Oct 23. J Biol Chem. 2004. PMID: 14576155 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page